Phase II clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neoadjuvant treatment in stages II and IIIA HER2-overexpressing breast cancer patients. GEICAM 2003-03 study (Q84526367)
Jump to navigation
Jump to search
scientific article published on 05 July 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neoadjuvant treatment in stages II and IIIA HER2-overexpressing breast cancer patients. GEICAM 2003-03 study |
scientific article published on 05 July 2010 |
Statements
Phase II clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neoadjuvant treatment in stages II and IIIA HER2-overexpressing breast cancer patients. GEICAM 2003-03 study (English)
A Antón
A Ruiz
A Plazaola
L Calvo
M A Seguí
A Santaballa
M Muñoz
P Sánchez
A Miguel
E Carrasco
J Lao
J Camps
J Alfaro
S Antolín